Visceral leishmaniasis in a psoriatic arthritis patient treated with methotrexate

Visceral leishmaniasis, in Greece, represents a relatively rare, potentially fatal clinical entity. Here we describe a case of visceral leishmaniasis infection in a 65-year old Greek male with psoriatic arthritis treated with methotrexate, who presented with high grade fever, chills, splenomegaly, p...

Full description

Saved in:

Bibliographic Details
Published in:	Le infezioni in medicina Vol. 22; no. 3; pp. 230 - 235
Main Authors:	Hadjipetrou, Athanasios, Anyfantakis, Dimitrios, Gkogkou, Argyro, Palla, Katerina, Lagoudaki, Eirini, Milonaki, Theoharoula, Kastanakis, Serafim
Format:	Journal Article
Language:	English
Published:	Italy 01-09-2014
Subjects:	Aged Arthritis, Psoriatic - complications Arthritis, Psoriatic - drug therapy Humans Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Leishmaniasis, Visceral - chemically induced Male Methotrexate - adverse effects Methotrexate - therapeutic use
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Visceral leishmaniasis, in Greece, represents a relatively rare, potentially fatal clinical entity. Here we describe a case of visceral leishmaniasis infection in a 65-year old Greek male with psoriatic arthritis treated with methotrexate, who presented with high grade fever, chills, splenomegaly, pancytopenia and polyclonal hypergammaglobulinaemia. A diagnosis of visceral leishmaniasis was finally established. Visceral leishmaniasis should be included in the differential diagnosis for infections in patients receiving methotrexate for rheumatic diseases, especially in endemic areas.
Bibliography:	ObjectType-Case Study-3 SourceType-Scholarly Journals-1 content type line 23 ObjectType-Review-1 ObjectType-Feature-5 ObjectType-Report-2 ObjectType-Article-4
ISSN:	1124-9390